The expanding application of antisense oligonucleotides to neurodegenerative diseases.

J Clin Invest · 2024 · PMC11444189 · PMID 39352381

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Despite this, tofersen failed to reach significance on the primary outcome of the ALS functional rating scale at 6 months ( 10 ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.